|
 |
 |
|
|
 |
|
Together, we can beat prostate cancer!
The Prostate Cancer Institute incorporates an holistic, integrated model that will rely heavily on health care and research professionals with specific skills in the field of prostate cancer. The team approach, on which the PCI model of care is based, is vital to obtaining the best results for men and their families. This holistic integrated team approach is refined at the PCI to a level not available at any other place in NSW. The composition of the therapeutic team reflects the need to provide optimum treatment, underpinned by education, advice and quality targeted research. Together, we can do it!
|
Dr. William Lynch |
Dr. Peter Aslan |
Dr. Peter Nash |
Dr. Paul Cozzi |
Dr. Edward Korbel |
Dr. David Malouf |
Dr. Gerard Testa |
Dr. Bill Papadopolpous |
Dr. William Lynch
Completed his medical degree at the University of NSW. After receiving his Australasian Fellowship in Urology he undertook further training at The Royal London Hospital and London University. This time in London had its main focus in oncology and neuro-urology. From this time his continuing interests have been in the development of minimally invasive techniques for the treatment of benign and malignant prostate disease and lower urinary tract function.
Dr. Peter Aslan
Dr Aslan graduated from Sydney University in 1988. He completed Urology training in Sydney and in 1997 was the first Australian to obtain a fellowship in endourology at Duke University in North Carolina, the fourth largest medical school in the United States. Dr Aslan is concentrating on laser and laparoscopic urological surgery specifically laproscopic partial nephrectomy, advancement in laparoscopic surgery and difficult stone surgery. Peter is appointed as a VMO at St George Private, St George Public and Sydney Private.
Dr. Peter Nash
Dr Nash graduated from the University of Sydney in 1984. He obtained his Fellowship in Urology in 1992 and completed clinical fellowships in Reconstructive Urology at the University of California, San Francisco and in Urologic Oncology at the Indiana University Medical Centre, before returning to Australia to pursue interest in these subspecialties. Dr Nash has academic appointments as a lecturer at both Sydney University and the University of NSW and currently hold appointments as a VMO at St George Private, the Mater Hospital, North Shore Private and Castlecrag Private Hospitals.
Dr. Paul Cozzi
Dr Cozzi graduated from UNSW in 1990. He completed Urology training and obtained the FRACS in 1999. He has a major interest in clinical and laboratory based research and completed a Masters in Surgery in 1998.
Dr Cozzi obtained fellowship training in Urologic Oncology at Memorial Sloan Kettering in New York between 1998-2000 and returned to Australia to take up a Senior Lecturer post at UNSW and St George Hospital.
He has published and presented papers widely and maintains an active research program at St George Hospital.
Dr. Edward Korbel
Dr Edward Korbel is Senior Urologist at Sutherland Hospital and has been practicing as a Consultant Urologist since 1977. He is a visiting Urologist to Sutherland, Prince of Wales , Kareena Private, Presidents Private and St. George Private Hospitals.
His interests are General Urology, Urological Oncology, specifically brachytherapy, and surgical treatment or urological malignancies. Dr Korbel is the Director of the Urological Foundation of Australasia.
Dr. David Malouf
Dr Malouf graduated from the University of Sydney in 1990. After completing his Australasian Urological training and undertook further training in London at the Hammersmith Hospital in Uro-Oncology and Renal Transplantation. His sub-speciality interests include Prostate Brachytherapy, Laparoscopy and Endourology.
He currently is a VMO at St. George and Canterbury Public Hospitals, in addition to St. George Private, Kareena and President Private.
Dr. Bill Papadopolpous
Dr Papadopoulos graduated from the University of Sydney in 1995. After completing his urology training in Sydney, he undertook a 1-year fellowship at the Nottingham University Hospital in the UK where he worked with many world renowned, well respected specialists. His interests include endourology, laparoscopy, minimally invasive surgery, uro-oncology, benign and malignant prostate disease and brachytherapy. He is a VMO at Sutherland Hospital, St George Private and Kareena Private Hospital. |
|
Professor J H Kearsley |
Dr. Joseph Bucci |
Dr Yaw Chin |
Professor J H Kearsley
Professor Kearsley graduated from the University of Sydney in 1977 and is Director of the Division of Cancer Services at St. George Hospital, and adjunct professor within the University of New South Wales. Professor Kearsley was trained as both a Medical Oncologist and a Radiation Oncologist, and was awarded a PhD degree in 1992 for his thesis which dealt with the pathology of head and neck cancers. Professor Kearsley has a wide range of interests in Oncology from laboratory, scientific techniques through to quality of life and palliative care issues in oncology. He has published in excess of 100 peer-reviewed manuscripts in the world literature and was formally the Honorary Medical Director of the National Breast Cancer Centre. In developing the Prostate Cancer Institute, Professor Kearsley has exhibited his skills in team building, communication and the establishment of new cancer services.
Dr. Joseph Bucci
Dr Bucci completed his medical degree at the University of Sydney in 1988. he attained his fellowship in Medical Oncology in 1997 and subsequently his Fellowship to the Royal Australian and New Zealand College of Radiologists in Radiation Oncology in 2000. He subsequently completed a 12-month overseas fellowship at the British Columbia Cancer Agency in Vancouver and attained formal accreditation in the prostate seed brachytherapy procedure by the Agency.
Dr Bucci’s interest include the use of brachytherapy for prostate cancer and external beam radiotherapy for genito-urinary malignancies. He is accredited as a staff specialist in Radiation Oncology at the “Prostate Cancer Institute St. George Hospital Cancer Care Centre, Sutherland Hospital and also holds an appointment at St. George Private Hospital.
Dr Yaw Chin
Dr. Chin graduated from the University of NSW in 1997 and obtained his fellowship in Radiation Oncology in 2004. He was selected as the Windeyer Fellow of the Royal Australian and New Zealand College of Radiologists from 2004 to 2006 where he undertook specific training in prostate brachytherapy. Since his return to Sydney, he has been working at St. George Hospital Cancer Care Centre as a staff specialist and has continued his keen interest in the management and research of urological malignancies. |
|
Dr. Paul de Souza |
Dr. Paul de Souza
Dr Paul de Souza graduated from Sydney University in 1986, completed his Medical Oncology training at St. George and Prince of Wales Hospitals and received his fellowship of the Royal Australasian College of Physicians in 1992. After studying for a Master of Public health degree whilst he was a Senior Medical Registrar, he pursued specific training in translational cancer research in the United States. Dr de Souza became a Research Associate and Assistant professor of Medicine at the University of Virginia, Charlottesville, Virginia, where he developed his clinical and research interests in cancer drug development and urological cancers. He returned to Sydney in 1997 and founded the Clinical Trials Unit in the Cancer Care Centre at St. George Hospital, as well as a research laboratory dedicated to developing new drugs and approaches for the treatment of prostate and other urological cancers. Paul has had a longstanding research and clinical interest in many aspects of prostate cancer and is appointed as a Senior Staff Specialist at St. George Public and Sutherland Hospitals and a VMO at St. George Private Hospital. |
|
Professor Anatoly Rosenfeld |
Professor Barry Allen |
Dr. Raymond Clarke |
Dr. Peter Galettis |
Professor Barry Allen
Professor Barry J Allen PhD DSc
Barry Allen is a biomedical physicist in the S George Cancer Care Centre and Clinical School at St George Hospital in Sydney. Previously, he worked at ANSTO as a Chief Research Scientist, the highest research grade at ANSTO. During this time he published widely in keV neutron capture reactions, investigating neutron capture mechanisms and their relationship to stellar nucleosynthesis and cross section data for fast reactors. He published 103 papers in these fields, was the first PhD graduate of the University of Wollongong in 1977and took out his DSc with the University of Melbourne in 1984.
In the early 1980’s Barry turned his attention to the application of neutrons in medicine. He quickly began R&D programs in Boron Neutron Capture Therapy (BNCT) for cancer and In Vivo Body Composition (IVBC). He was able to put together multidisciplinary teams that made major contributions to both these fields. He designed the in vivo nude mouse irradiation facility at the Moata reactor, which allowed the first demonstration of the efficacy of BNCT in the local control of human melanoma in nude mice. In collaboration with the Peter MacCallum Cancer Institute, double strand breaks in DNA arising from neutron capture induced auger emission were demonstrated for the first time. Barry went on to become President of the International Society for Neutron Capture Therapy and to convene the Fourth International Symposium in Sydney in 1990.
Barry made the first human body protein measurements in Australia at Lucas Heights, in collaboration with Sydney hospitals, and the prototype Body Protein Monitor was installed at RNSH, where it continues to operate today. The first commercial Body Protein Monitor was designed and produced, and one unit is located at the New Children’s Hospital at Westmead. Barry left ANSTO in 1994 to take up a position as Head, Biomedical Physics Research, in the Division of Cancer Services at St George Hospital.
In the early 90’s Barry convened information meetings in Experimental Radiation Oncology and later IVBC. The Centre for Experimental Radiation Oncology was formed in 1997 at St George Hospital, and the Centre for IVBC in 1998 at Royal North Shore Hospital.
The Targeted Alpha Therapy (TAT) project was started at St George Hospital, where Barry put together a small multidisciplinary team with US funding. This program was particularly successful in developing new agents for the treatment of melanoma, leukaemia, breast, prostate and colorectal cancer. Some 30 papers have now been published in international journals on this topic, and a world first trial of intralesional TAT for melanoma commenced in 2001. This was followed by a systemic phase 1 trial in 2004, for which many responses were observed, including one complete response, which has left the patient disease free for seven months.
Barry has published some 275 papers in neutron capture gamma ray, resonance cross-sections, stella nucleosynthesis, IVBC, BNCT, macro and micro-dosimetry, microbeams and targeted alpha therapy. Successful collaborative grant applications total some $4 million. Barry is a Professional Fellow of the University of Sydney (1992), Wollongong (1992) and Adjoint Professor Physics at UNSW (1997-2004) and recently was appointed Conjoint Professor in the Clinical School of the University of NSW (2004). He was a Fellow of the Australian Institute of Physics (1972) and the American Physical Society (1981), and is a Fellow of the ACPSEM (1992) and of the Institute of Physics (1999).
After serving as President, NSW Branch of the Australasian College of Physical Scientists and Engineers in Medicine (1995-7), Barry was elected College President in 1998. He initiated and led the successful bid for the International Conference on Medical Physics and Biomedical Engineering in 2003 at Sydney. Barry was elected President of the Asia Oceania Federation of Medical Physics and President-Elect of the International Organisation of Medical Physics in 2003.
Dr. Raymond Clarke
RAYMOND ALLAN CLARKE
ST GEORGE CLINICAL SCHOOL
ST GEORGE HOSPITAL UNIVERSITY of NSW
KOGARAH NSW 2217, AUSTRALIA
Tel.: 0425-210-270; 61-2-9350-2994 (w); Fax.: 61-2-9350-3958
r.clarke@unsw.edu.au
Dr Clarke has a PhD in Biochemistry and Molecular Genetics. He is currently Principal Scientific Officer, Adjunct Senior Lecturer and Director of the Human Cancer Genetics Research Group at the Cancer Care Centre
Gene expression profiling in Familial Prostate Cancer.
A local family with a very high incidence of Prostate Cancer (4 of 5 brothers affected) has enabled Dr Clarke of the Cancer Genetics Research Group to identify important genes implicated in Prostate Cancer.
We have successfully employed a sophisticated form of gene expression profiling called ‘HiCEP’ to positively identify prostate cancer genes from this local family. We have independently identified 3 excellent candidate prostate cancer genes two of which are implicated in normal prostate metabolism by virtue of their interrelationship with the male hormone – testosterone and the androgen receptor.
We have now broadened this study to test for the relevance of these genes in other prostate cancer patients. You may wish to assist by helping with Caps For Cancer® raise research funding that will be directed to using these genes to provide a genetic screen for men at risk of prostate cancer. Dr R. Clarke
Dr. Peter Galettis
Dr Peter Galettis, is a Senior Scientific Officer with the Department of Medical Oncology at the St George Hospital Cancer Care Centre, a position he has held since 2000. He was responsible for the establishment of the Cancer Pharmacology and Therapeutics laboratory, where the research focus is on refining the mechanisms of action of anticancer drugs especially through the use of pharmacogenetic information to directly improve treatment of patients within the centre. He also holds the position of Conjoint Lecturer with the St George Clinical School, UNSW. Prior to St George, Peter worked for several years at the University of Auckland, in New Zealand researching the metabolism and mechanisms of action of platinum and gold anti-cancer compounds. |
|
Dr. Terrence Diamond |
Dr. Terrence Diamond
Dr Diamond is a senior consultant in Endocrinology at SGH, the Head of the Metabolic Bone Unit and a Scientific Member of Osteoporosis Australia. His title is Associate Professor of Medicine, University of New South Wales, MBBCh, MRCP, FRACP.
Dr Diamond’s research interests include osteoporosis in men, acute vertebral fractures and malignant bone disease. For the past 10 years, our group has been studying bone diseases related to prostate cancer and the effects of chronic androgen deprivation therapy. In 2004, we (panel of Experts from the USA and Australia) published ‘Guidelines for managing men with prostate cancer receiving androgen deprivation therapy’ in the journal CANCER. His ongoing research is to focus on medications preventing osteoporosis in this cohort. |
Jacqueline Lim |
Jacqueline Lim
Jacqueline Lim is based at the Cancer Care Centre, St George Hospital. She is experienced in working with people who are adjusting to life after a diagnosis of cancer. Jacqueline is committed to providing evidence based therapy for patients who may be experiencing difficulties coping with their cancer diagnosis and treatments. She provides individual therapy to patients who are referred by their oncologists, and is available to present various relevant psychological topics to cancer support groups. Her expertise includes dealing with anxiety, depression, pain, body image, sexual problems, communication, psychological adjustment to illness and relationship difficulties.
Jacqueline completed her Masters in Clinical Psychology at the University of New South Wales in 1997. She has held research positions in University of NSW and Sydney University, and clinical positions in both private and public hospitals. Working with cancer patients and their families has long been an area of interest for her. One of her on-going clinical interests is cancer survivorship; in conjunction with the Centre for Values, Ethics and Law in Medicine (Sydney University), she has conducted several workshops for cancer survivors and health professionals (2001-2003). Jacqueline was first appointed at the Cancer Care Centre in 2003. She initiated a men’s cancer group, recognising there was a need in this area. |
Pauline Thomson |
Pauline Thomson
Pauline Thomson is the Prostate Cancer Nurse Coordinator (CNC) at the St. George Hospital Cancer Care Centre. It is a new position funded by the NSW Cancer Institute. Pauline graduated from the University of Western Sydney in 1987 with a Dip. Applied Science (Nursing) and Graduate Certificate in Oncology Nursing from the NSW College of Nursing. She is also a member of the Cancer Nurses’ Society of Australia (CNSA).
Pauline commenced working in Oncology / Haematology in 1988 and has a wide range of experience in Oncology and Haematology patient care, Palliative Care, chemotherapy administration and Radiation Oncology. She commenced working in Radiation Oncology in 1997 and has a great deal of experience in not only external beam radiation, but in high dose rate (HDR) and radioactive seed brachytherapy.
Pauline’s role as the Prostate CNC is to focus on new patients coming to the St. George Cancer Care Centre for treatment of their prostate cancer. Her role is to coordinate and explain the treatment process to the patient and their family and to act as a link between the doctors, the patients and other members of the multidisciplinary team.
|
|
|
| | |
